2025-07-05 - Analysis Report
Okay, here's a report analyzing TG Therapeutics Inc. (TGTX) based on the provided data.

## TG Therapeutics Inc. (TGTX) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** TGTX
*   **Company Description:** TG Therapeutics Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
*   **TGTX Cumulative Return:** 63.15%
*   **VOO Cumulative Return:** 95.42%
*   **Absolute Divergence (TGTX - VOO):** -36.1
*   **Relative Divergence:** 14.5

**Analysis:** TGTX has underperformed the S&P 500 (VOO) significantly, with a cumulative return lagging by 36.1%. The relative divergence of 14.5 suggests that TGTX's performance is in the lower range of its historical performance relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR  | MDD  | Alpha  | Beta  | Cap(B) |
|------------|-------|------|--------|-------|--------|
| 2015-2017  | -6.0% | 56.5% | -35.0% | -0.1  | 1.3    |
| 2016-2018  | -8.0% | 58.6% | -26.0% | 0.0  | 0.7    |
| 2017-2019  | 74.0% | 58.6% | 44.0%  | 0.0  | 1.8    |
| 2018-2020  | 402.0% | 58.6% | 382.0% | -0.4 | 8.3    |
| 2019-2021  | 125.0% | 63.5% | 76.0%  | -0.5 | 3.0    |
| 2020-2022  | -76.0% | 70.4% | -78.0% | -0.6 | 1.9    |
| 2021-2023  | -350.0% | 70.4% | -368.0% | -0.8 | 2.7    |
| 2022-2024  | 71.0% | 73.1% | 45.0%  | -0.9 | 4.8    |
| 2023-2025  | 70.0% | 73.1% | 23.0%  | 0.4 | 5.8    |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant volatility in TGTX's returns over different periods, ranging from negative values to over 400%.
*   **MDD:** The Maximum Drawdown (MDD) indicates substantial risk, with drawdowns consistently exceeding 50%.
*   **Alpha:** Alpha is generally negative, suggesting underperformance relative to the benchmark.
*   **Beta:** Beta values fluctuate, indicating varying degrees of correlation with the market.
*   **Cap(B):** The market capitalization grows from 1.3B to 5.8B throughout the periods shown

### 2. Recent Price Action

*   **Current Price:** 36.72
*   **Previous Close:** 36.29
*   **Change:** 1.18 (Indicates a slight positive movement)
*   **5-day Moving Average:** 36.286
*   **20-day Moving Average:** 37.1323
*   **60-day Moving Average:** 37.0905

**Analysis:** The current price is above the 5-day moving average but below the 20 and 60-day moving averages, suggesting potential short-term upward momentum but possible resistance at the longer-term averages. The recent price increase of 1.18 indicates a positive change.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 46.49 (Neutral)
*   **PPO:** -0.10 (Slightly Bearish)
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (127 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** -1.5 (Short-term Decrease)
*   **Expected Return (%):** -274.0%

**Analysis:**

*   The low MRI suggests a relatively stable market environment.
*   The RSI of 46.49 is neutral, not indicating overbought or oversold conditions.
*   A negative PPO indicates slight bearish momentum.
*   The hybrid signal suggests caution and recommends a partial buy.
*   The negative change in relative divergence suggests a short-term downward trend.
*   The extremely negative expected return raises significant concerns about long-term investment potential.

### 4. Recent News & Significant Events

*   **2025-07-01:** Major business developments, regulatory changes, or market events.
*   **2025-07-04:** Analysts discussing performance in the context of industry and global economics.
*   **2025-07-03:** Notable stock volatility.
*   **2025-07-02:** Market experts highlight risks and opportunities.

**Analysis:** Recent news suggests TGTX is experiencing significant events leading to volatility. Analysts are actively discussing the company's performance, and experts advise monitoring news closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-09 | 0.03  | 0.12 B$   |
| 2024-11-07 | 0.03  | 0.08 B$   |
| 2024-08-09 | 0.05  | 0.07 B$   |
| 2024-05-06 | -0.07 | 0.06 B$   |
| 2025-05-09 | -0.07 | 0.06 B$   |

**Analysis:** The earnings data reveals a mixed performance. Recent EPS values are positive (0.03, 0.03, and 0.05), indicating profitability, while the prior EPS values had negative values. Revenue has shown increasing growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.12B  | 87.14%        |
| 2024-12-31 | $0.11B  | 85.77%        |
| 2024-09-30 | $0.08B  | 88.86%        |
| 2024-06-30 | $0.07B  | 88.70%        |
| 2024-03-31 | $0.06B  | 91.43%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | $0.24B  | 2.13%   |
| 2024-12-31 | $0.22B  | 10.49%  |
| 2024-09-30 | $0.19B  | 2.02%   |
| 2024-06-30 | $0.18B  | 3.87%   |
| 2024-03-31 | $0.16B  | -6.69%  |

**Analysis:** The financial data shows strong revenue growth and high-profit margins. Equity is also increasing, but the ROE is volatile, indicating fluctuations in profitability relative to equity.

### 7. Overall Analysis and Conclusion

TGTX has underperformed the S&P 500, and its historical performance has been volatile, as indicated by the CAGR and MDD figures. Recent news suggests the company is undergoing significant changes, contributing to stock volatility. The earnings data show mixed profitability. While revenue growth and profit margins are strong, the negative expected return raises serious concerns. The hybrid signal recommends a cautious approach.

**Recommendation:** Given the underperformance, volatility, and negative long-term expected return, investors should exercise caution. Monitoring the news and company announcements closely is crucial due to the ongoing developments and potential risks.
